A photograph illustration depicting gene enhancing. Utilizing its new ProGen3 AI mannequin, biotech startup Profluent has developed new gene enhancing proteins which may be more practical than the CRISPR-Cas9 programs that underpin most modern gene enhancing therapies.
Photograph illustration—Getty Photographs
